Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo

Clinical Trial

A Calle-Pascual et al. Diabetes Metab. 1996 Jun.

. 1996 Jun;22(3):201-2.

No abstract available

Cited by

Glucose supply and insulin demand dynamics of antidiabetic agents.
Monte SV, Schentag JJ, Adelman MH, Paladino JA. Monte SV, et al. J Diabetes Sci Technol. 2010 Mar 1;4(2):365-81. doi: 10.1177/193229681000400219. J Diabetes Sci Technol. 2010. PMID: 20307399 Free PMC article.
Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus.
Lin C, Cai X, Yang W, Lv F, Nie L, Ji L. Lin C, et al. BMC Med. 2020 Nov 16;18(1):322. doi: 10.1186/s12916-020-01787-4. BMC Med. 2020. PMID: 33190640 Free PMC article.
Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C. Van de Laar FA, et al. Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD003639. doi: 10.1002/14651858.CD003639.pub2. Cochrane Database Syst Rev. 2005. PMID: 15846673 Free PMC article.
"Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.
Yajima K, Shimada A, Hirose H, Kasuga A, Saruta T. Yajima K, et al. Rev Diabet Stud. 2004 Summer;1(2):89-94. doi: 10.1900/RDS.2004.1.89. Epub 2004 Aug 10. Rev Diabet Stud. 2004. PMID: 17491670 Free PMC article.
Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
Rabasa-Lhoret R, Chiasson JL. Rabasa-Lhoret R, et al. Drugs Aging. 1998 Aug;13(2):131-43. doi: 10.2165/00002512-199813020-00005. Drugs Aging. 1998. PMID: 9739502 Review.